Skyscape Web Viewer : Pharmacy Practice and the Law : Main Index

View All
See maximum allowable cost (MAC) program Overview of Important Developments in Medicaid and Prescription Drug Reimbursement See maximum allowable cost (MAC) program
Magan Medical Clinic v. Board of Medical Examiners (1976)
Magrine v. Krasnica (1971)
ma huang plant
mailing controlled substances, regulation
mail-order drug outlets Explanation of the Durham-Humphrey Amendment Licensing of Pharmacies
maintenance treatment, opioid addiction
Makripodis v. Merrell-Dow Pharmaceuticals (1987)
Malan v. Huesemann (1997)
malpractice insurance
malpractice
managed-care plans formularies, regulation of
manufacturer recall notices
manufacturing Compliance Policy Guide 1992 Compliance Policy Guide 2002 defined draft compliance guides Drug Quality and Security Act of 2013 (DQSA) labeling and packaging of controlled substances new drug issue other issues patent issues pharmacy compounding vs. Pharmacy Compounding vs Manufacturing registration overview USP compounding requirements
marijuana, medical
marketed unapproved drugs
market failures
marketing
Marshall v. Barlow's Inc. (1978)
Massachusetts Pharmaceutical Association v. Rate Setting Commission (1982)
maximum allowable cost (MAC) program
McCarran-Ferguson Act
McKee v. American Home Products, Inc. (1989)
McLeod v. W.S. Merrell Co. (1965)
See Medical Device Amendments of 1976 (MDA) Defining and Distinguishing Drugs from Foods, Dietary Supplements, Devices, and Cosmetics Drugs vs Devices Medical Device Amendments of 1976 Medical Devices Safe Medical Devices Act of 1990 See Medical Device Amendments of 1976 (MDA)
Medicaid dispensing fees
Medicaid Maximum Allowable Cost Program in 1974
Medicaid
Medical Arts Pharmacy of Stanford Inc.v. Blue Cross and Blue Shield of Connecticut, Inc. (1981)
Medical Center Pharmacy v. Gonzales (2006)